There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC C07D403/04
Pages in category "CPC C07D403/04"
The following 49 pages are in this category, out of 49 total.
1
2
- 20250154128. A Process For Making Osimertinib (Synthon B.V.)
- 20250154129. Crystalline Pharmac (VIVORYON THERAPEUTICS N.V.)
- 20250206722. Small Molecule (The Scripps Research Institute)
- 20250214973. 1,4,5-trisubstituted (UNIVERSITY OF PUERTO RICO)
- 20250214974. Inhibiting Monoacylglyc (Psy Therapeutics, .)
- 20250230145. Crystalline Forms Carbazole Inhi (MBQ Pharma)
A
B
- BASF SE Patent Application Trends in 2025
- Bayer Aktiengesellschaft Patent Application Trends in 2025
- Board of Regents, The University of Texas System Patent Application Trends in 2024
- BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM Patent Application Trends in 2024
- Boehringer Ingelheim International GmbH Patent Application Trends in 2025
- Brown University Patent Application Trends in 2025
C
M
N
P
R
S
- Samsung Display Co., LTD Patent Application Trends in 2024
- SAMSUNG DISPLAY CO., LTD. Patent Application Trends in 2024
- Samsung Display Co., Ltd. Patent Application Trends in 2024
- SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Patent Application Trends in 2024
- SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Patent Application Trends in 2025
T
- TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent Application Trends in 2024
- The General Hospital Corporation Patent Application Trends in 2024
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024
- The Regents of The University Of California Patent Application Trends in 2025
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN Patent Application Trends in 2024